CLINICAL_TRIALS
trial_result
· 2025-12-19
Clinical Trial Update: Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies [Phase 1]
Summary
Phase 1 study of INCB040093 in subjects with previously treated B-cell malignancies; the trial is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: B-cell Malignancies | Phase 1 | Status: ACTIVE_NOT_RECRUITING